Biomea Fusion Stock Market Value
| BMEA Stock | USD 3.73 0.12 3.32% |
| Symbol | Biomea |
Biomea Fusion Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomea Fusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biomea Fusion 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biomea Fusion's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biomea Fusion.
| 03/01/2023 |
| 02/18/2025 |
If you would invest 0.00 in Biomea Fusion on March 1, 2023 and sell it all today you would earn a total of 0.00 from holding Biomea Fusion or generate 0.0% return on investment in Biomea Fusion over 720 days. Biomea Fusion is related to or competes with Edgewise Therapeutics, Werewolf Therapeutics, Cullinan Oncology, Design Therapeutics, and Ikena Oncology. Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule dr... More
Biomea Fusion Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biomea Fusion's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biomea Fusion upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 28.29 | |||
| Value At Risk | (8.98) | |||
| Potential Upside | 6.48 |
Biomea Fusion Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biomea Fusion's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biomea Fusion's standard deviation. In reality, there are many statistical measures that can use Biomea Fusion historical prices to predict the future Biomea Fusion's volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (1.06) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | (0.32) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biomea Fusion's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biomea Fusion Backtested Returns
Biomea Fusion secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15 % return per unit of risk over the last 3 months. Biomea Fusion exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biomea Fusion's Standard Deviation of 5.07, mean deviation of 3.59, and Risk Adjusted Performance of (0.14) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 3.34, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biomea Fusion will likely underperform. At this point, Biomea Fusion has a negative expected return of -0.74%. Please make sure to confirm Biomea Fusion's skewness, rate of daily change, and the relationship between the value at risk and accumulation distribution , to decide if Biomea Fusion performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.16 |
Very weak predictability
Biomea Fusion has very weak predictability. Overlapping area represents the amount of predictability between Biomea Fusion time series from 1st of March 2023 to 24th of February 2024 and 24th of February 2024 to 18th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biomea Fusion price movement. The serial correlation of 0.16 indicates that over 16.0% of current Biomea Fusion price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.16 | |
| Spearman Rank Test | 0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 15.46 |
Biomea Fusion lagged returns against current returns
Autocorrelation, which is Biomea Fusion stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biomea Fusion's stock expected returns. We can calculate the autocorrelation of Biomea Fusion returns to help us make a trade decision. For example, suppose you find that Biomea Fusion has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biomea Fusion regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biomea Fusion stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biomea Fusion stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biomea Fusion stock over time.
Current vs Lagged Prices |
| Timeline |
Biomea Fusion Lagged Returns
When evaluating Biomea Fusion's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biomea Fusion stock have on its future price. Biomea Fusion autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biomea Fusion autocorrelation shows the relationship between Biomea Fusion stock current value and its past values and can show if there is a momentum factor associated with investing in Biomea Fusion.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biomea Fusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomea Fusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomea Fusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomea Fusion Stock:Check out Biomea Fusion Correlation, Biomea Fusion Volatility and Biomea Fusion Alpha and Beta module to complement your research on Biomea Fusion. For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Biomea Fusion technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.